Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Opioids: FDA Eyes Better Prescriber Education, But Academics Urge Promotion Crackdown

Apr 20 2017

• By Sue Sutter

Watch gears up close

Related Content

Califf Nomination Suffers 'Pile On': What Can FDA Do To Break Logjam?

Feb 01 2016

Restrictive REMS Is Least Favored Path For Opioid Prescriber Education

May 09 2016

Opioids May All Require Mandatory Education As US FDA Expands REMS To Immediate-Release Formulations

Dec 20 2016

FDA's Commissioner Fish Story Continues

Apr 19 2017

Opioid Policy At US FDA: Gottlieb Seeks More Activist Role To Combat Abuse

Apr 07 2017

Additional Topics

United States Drug Safety Risk Management Regulation Neurology BioPharmaceutical

More from Drug Safety

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window